Skip to main content

Vaginal Dryness

1
Pipeline Programs
4
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Shionogi
ShionogiJapan - Osaka
1 program
1
OspemifenePhase 31 trial
Active Trials
NCT02638337Completed631Est. Jul 2017
Biocodex
BiocodexFrance - Gentilly
2 programs
Mucogyne GelN/A1 trial
Mucogyne OvuleN/A1 trial
Active Trials
NCT05913479Completed34Est. Jan 2026
NCT06282614Terminated33Est. Feb 2025
Innovation Pharmaceuticals
1 program
Moisturizing vaginal and vulvar sea buckthorn oil creamN/A1 trial
Active Trials
NCT02937805Completed225Est. Sep 2017
Zambon
ZambonItaly - Bresso
1 program
Vaginal gel, Medical Device Class 2AN/A1 trial
Active Trials
NCT02994342Completed121Est. Oct 2015

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
ShionogiOspemifene
BiocodexMucogyne Ovule
BiocodexMucogyne Gel
Innovation PharmaceuticalsMoisturizing vaginal and vulvar sea buckthorn oil cream
ZambonVaginal gel, Medical Device Class 2A

Clinical Trials (5)

Total enrollment: 1,044 patients across 5 trials

NCT02638337ShionogiOspemifene

Study to Evaluate Ospemifene in Patients With Moderate to Severe Vaginal Dryness Due to Menopause

Start: Jan 2016Est. completion: Jul 2017631 patients
Phase 3Completed
NCT06282614BiocodexMucogyne Ovule

Performance and Safety of MUCOGYNE® Ovule as a Moisturizer

Start: Apr 2024Est. completion: Feb 202533 patients
N/ATerminated
NCT05913479BiocodexMucogyne Gel

Evaluation of the Efficacy and Safety of Mucogye® Gel as a Moisturizer

Start: Oct 2023Est. completion: Jan 202634 patients
N/ACompleted
NCT02937805Innovation PharmaceuticalsMoisturizing vaginal and vulvar sea buckthorn oil cream

Effects of a Moisturizing Cream on Vaginal and Vulvar Mucous Membranes

Start: Oct 2016Est. completion: Sep 2017225 patients
N/ACompleted
NCT02994342ZambonVaginal gel, Medical Device Class 2A

Efficacy and Tolerability Study of ZP-025 Vaginal Gel for the Treatment of Vaginal Dryness

Start: Oct 2012Est. completion: Oct 2015121 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.